Zeleris

1 x 50 ml

Liquid for injection, solution

Active substance

Florfenicol : 400 mg/ml

Meloxicam : 5 mg/ml

ATC code

QJ01BA99 Amphenicols, comb.

QJ01BA Amphenicols

QJ01B Amphenicols

QJ01 Antibacterials for systemic use

QJ Antiinfectives for systemic use

Species

Cattle.

Indications

For therapeutic treatment of bovine respiratory disease (BRD) due to Histophilus somni, Mannheimia haemolytica, Pasteurella multocida and Mycoplasma bovisassociated with pyrexia.

Dose to be administered and administration route

Subcutaneous use.

A single subcutaneous injection at a dosage of 40 mg florfenicol/kg bodyweight and 0.5 mg meloxicam/ kg bodyweight (i.e. 1 ml/10 kg bodyweight).

The single dose volume should not exceed 15 ml per injection site. The injection should only be given in the neck area.

To ensure a correct dosage, bodyweight should be determined as accurately as possible.

For the 250 ml vials, the rubber stopper may safely be punctured up to 20 times. Otherwise, the use of a multiple-dose syringe is recommended.

Adverse reactions

Cattle:

Very common

(>1 animal / 10 animals treated):

Injection site swelling, Injection site induration, Injection site warmth, Injection site pain*

Undetermined frequency

(cannot be estimated from the available data):

Immediate pain upon injection**

* Usually resolve without treatment within 5 to 15 days but could persist up to 49 days.

** Pain at injection site is of moderate severity and manifested as head or neck movement.

Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or the national competent authority via the national reporting system. See also the last section ‘Contact details’ of the package leaflet